(2S,5R)-5-(aminomethyl)-N-[6-(trifluoromethoxy)-1,3-benzothiazol-2-yl]oxolane-2-carboxamide;hydrochloride
C14H15ClF3N3O3S — CID 120784969
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2S,5R)-5-(aminomethyl)-N-[6-(trifluoromethoxy)-1,3-benzothiazol-2-yl]oxolane-2-carboxamide;hydrochloride
(2S,5R)-5-(aminomethyl)-N-[6-(trifluoromethoxy)-1,3-benzothiazol-2-yl]oxolane-2-carboxamide;hydrochloride (PubChem CID 120784969) has the molecular formula C14H15ClF3N3O3S and a molecular weight of 397.81 g/mol. Its IUPAC name is (2S,5R)-5-(aminomethyl)-N-[6-(trifluoromethoxy)-1,3-benzothiazol-2-yl]oxolane-2-carboxamide;hydrochloride.
Molecular Properties
| Compound Name | (2S,5R)-5-(aminomethyl)-N-[6-(trifluoromethoxy)-1,3-benzothiazol-2-yl]oxolane-2-carboxamide;hydrochloride |
|---|---|
| PubChem CID | 120784969 |
| Molecular Formula | C14H15ClF3N3O3S |
| Molecular Weight | 397.81 g/mol |
| Exact Mass | 397.05 |
| IUPAC Name | (2S,5R)-5-(aminomethyl)-N-[6-(trifluoromethoxy)-1,3-benzothiazol-2-yl]oxolane-2-carboxamide;hydrochloride |
| SMILES | Cl.NC[C@H]1CC[C@@H](C(=O)Nc2nc3ccc(OC(F)(F)F)cc3s2)O1 |
| InChI | InChI=1S/C14H14F3N3O3S.ClH/c15-14(16,17)23-7-1-3-9-11(5-7)24-13(19-9)20-12(21)10-4-2-8(6-18)22-10;/h1,3,5,8,10H,2,4,6,18H2,(H,19,20,21);1H/t8-,10+;/m1./s1 |
| InChIKey | SFOYSGOQKKTZJA-SCYNACPDSA-N |
| XLogP | 3.06 |
| TPSA | 86.47 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 25 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 397.81 |
| LogP ≤ 5 | 3.06 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 120784969 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.